Biotech Fund Dumps Million: What It Signals for Investors
A major biotech-focused fund recently exited a large Nuvalent position, sparking questions about fund flows and stock...
Choosing between a Sep Ira and a Simple Ira can be challenging. Discover the key factors to consider for your retirement savings strategy.
15,615 articlesA major biotech-focused fund recently exited a large Nuvalent position, sparking questions about fund flows and stock...
Investors are buzzing as super micro computer stock jumps on a wave of bullish momentum. This piece breaks down the c...
NuScale Power's stock action sparks questions about small modular reactors and policy timelines. This guide breaks do...
A major biotech takeover bid sets the tone for today’s market. AbbVie’s cash offer for Apogee Therapeutics sent share...
A new AI-powered marketing platform is offering shares at $0.85 in a Reg A+ round, drawing comparisons to early Nvidi...
SpaceX sits at the frontier of aerospace and opportunity. This article breaks down the bold bets, the potential rewar...
A caller on The Ramsey Show turned $270K into $1.1M in three years, driven by four stock bets. Ramsey cautions that s...
A pivotal hearing in New York tests the CLARITY Act as Congress debates crypto rules. BTC, ETH and XRP face a regulat...
The White House confirms there are no pardon plans for Sam Bankman-Fried, despite ongoing social media activity from ...
Leaders are navigating a three-way test: grow economies, protect energy security, and push for sustainability. This b...
A wealth manager reduced its position in FIXD by 86,075 shares, cutting the value by roughly $3.8 million. This artic...
PIMCO dismisses Trump’s NATO exit threats as noise, calling them a paper tiger. The note arrives as investors weigh t...